1. Turkish Statistical Institute Population and Migration Statistics Group. Address based population registration system results 2015. Available at: http://www.turkstat.gov.tr Accessed March 2016.
2. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W; Global Advisory Panel Meeting on the Effects of Growth Hormone. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr 2013;102:787-796. Epub 2013 May 13
3. Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr 2014;164(Suppl 5):1-14.
4. De Onis M, Blössner M. WHO Global Database on Child Growth and Malnutrition. World Health Organization. Geneva, 1997. Available at: http://libdoc.who.int/hq/1997/WHO_NUT_97.4.pdf. Accessed May 2015.
5. Hacettepe University Institute of Population Studies. Turkey Demographic and Health Survey 2008. Ankara, 2009. Available at: http://www.hips.hacettepe.edu.tr/eng/tdhs08/TDHS-2008_Main_Report.pdf Accessed Dec 2015
6. Republic of Turkey Ministry of Health Turkish Public Health Institution, Department of Obesity, Diabetes and Metabolic Diseases Turkey Childhood (Ages 7-8) Obesity Surveillance Initiative (COSI-TUR) 2013. Ankara, 2014. Available at: http://www.halksagligiens.hacettepe.edu.tr/english/cosi_ing-2014.pdf Accessed Dec 2015
7. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958;18:901-903.
8. Darendeliler F. Safety of growth hormone treatment. J Clin Res Ped Endo 2009;1(Suppl 1):36-43.
9. Rosenbloom AL. Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr 2011;158:187-193. Epub 2010 Dec 18
10. Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of growth hormone/insulin-like growth factor secretion and action. In: Sperling MA (ed). Pediatric Endocrinology. 4th edition. Philadelphia, Elsevier Saunders, 2014:292-404.
11. Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 1999;84:4307-4316.
12. Turkish Pediatric Endocrinology and Diabetes Society webpage. Available at: www.cocukendokrindiyabet.org. Accessed Dec 2014.
13. Ulusal Pediatrik Endokrinoloji Derneği. Çocukluk ve ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavi uzlaşı raporu (Bölüm 1): Büyüme hormonu eksikliği tanısı. Çocuk Dergisi 2006;6:11-16. (in Turkish)
14. Bereket A, Özkan B, Kurtoğlu S. Turner sendromunda tanı ve tedavi: Ulusal Pediatrik Endokrinoloji Derneği olarak katkı. Çocuk Dergisi 2005;5:81-86. (in Turkish)
15. Berberoğlu M, Darendeliler F, Darcan S, et al. Çocukluktan erişkin döneme geçişte büyüme hormonu eksikliğinin değerlendirilmesi. Endokrinolojide Yönelişler 2004;13:133-136. (in Turkish)
16. Darendeliler F, Darcan S, Ulusal Pediatrik Endokrinoloji Derneği. Çocukluk ve ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavisi uzlaşı raporu (Bölüm 2): Büyüme hormonu eksikliği tedavisi. Çocuk Dergisi 2006;6:89-94. (in Turkish)
17. Minutes of the Turkish Pediatric Endocrinology and Diabetes Society and Turkish Adult Endocrinology and Metabolism Society. Workshop on Transition in Endocrine Patients. Coordinator: Kurtoğlu S, 9-10 Sept 2011, Kayseri. (in Turkish)
18. Bereket A, Büyükgebiz A, Özkan B, Darendeliler F, Berberoğlu M, Tarım Ö, Kurtoğlu S. Gestasyon yaşına göre küçük doğan bebeklerde (SGA) tanı ve tedavi önerileri: Novo Nordisk Danışma Kurulu. Endokrinde Yönelişler 2007;16:193-196. (in Turkish)
19. Darcan Ş, Arslanoğlu İ, Berberoğlu M, Bundak R, Yüksel B, Bideci A, Darendeliler F. Boy kısalığı tanım ve sınıflandırma: Aynı ölçütlerle mi boy kısalığı diyoruz? Ege Pediatri Bülteni 2006;13:127-133. (in Turkish)
20. Darendeliler F. Türkiyede TS’da Büyüme hormonu tedavisi ve güncel durum. Çocukluktan erişkinliğe Turner sendromu. Pediyatrik Endokrinoloji ve Oksoloji Derneği Sempozyumu II. 7 Haziran 2003, İstanbul. (in Turkish)
21. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001;11:137-165.
22. Ho KK; 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 2007;157:695-700.
23. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993.
24. Darendeliler F, Berberoğlu M, Öcal G. Büyüme hormonu eksikliği etiyolojisi, demografik veriler ve tedavi sonuçlarının değerlendirilmesi: Türkiye verileri. KIGS analiz sonuçları. Çocuk Dergisi 2004;4:141-148. (in Turkish)
25. Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO. Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol (Oxf) 2012;77:169-181.
26. Darcan Ş, Poyrazoğlu Ş, Çetinkaya S. Büyüme hormonu eksikliğinin tanısı. İçinde: Saka N, Akcay T (eds). Çocuk Endokrinolojisinde Uzlaşı. 1st edition. Nobel Tıp Kitabevleri, 2014:3-9.
27. Darendeliler F, Andıran N, Evliyaoğlu O, Uçkun Kitapçı A. Büyüme hormonu eksikliğinin tedavisi. İçinde: Saka N, Akcay T (eds). Çocuk Endokrinolojisinde Uzlaşı. 1st edition. Nobel Tıp Kitabevleri, 2015:11-24.
28. No authors listed. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995;127:857-867.
29. Darendeliler F. Büyüme Hormonu tedavisinde kanıta dayalı uygulamalar. Çocuk Dergisi 2009;9:158-166. (in Turkish)
30. Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, Savage MO. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. Horm Res 1998;50:320-340.
31. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P; Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415-421.
32. Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 2012;15:301-310.
33. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 2002;58:233-241.
34. Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995;80:3292-3297.
35. Poyrazoğlu Ş, Akçay T, Arslanoğlu İ, Atabek ME, Atay Z, Berberoğlu M, Bereket A, Bideci A, Bircan İ, Böber E, Can Ş, Cesur Y, Darcan Ş, Demir K, Dündar B, Ersoy B, Esen İ, Güven A, Kara C, Keskin M, Kurtoğlu S, Memioğlu N, Özbek MN, Özgen T, Sarı E, Şıklar Z, Şimşek E, Turan S, Yeşilkaya E, Yüksel B, Darendeliler F. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: A survey from Turkey. J Clin Res Pediatr Endocrinol 2015;7:37-44.
36. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormonedeficiency. Horm Res 2002;58:233-241.
37. Cappa M, Iughetti L, Loche S, Maghnie M, Vottero A; GeNeSIS National Board on behalf of theGeNeSIS Italian Investigators. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study. J Endocrinol Invest 2016;39:667-677. Epub 2015 Dec 28
38. Bereket A, Turan S, Elçioğlu N, Hacihanefioğlu S, Memioğlu N, Baş F, Bundak R, Darendeliler F, Günöz H, Saka N, Ercan O, Arslanoğlu I, Işgüven P, Yildiz M, Can S, Ozerkan E, Coker M, Darcan S, Ozkan B, Orbak Z, Oztaş S, Palandüz S, Sezgin I, Atabek E, Erkul I, Erdoğan G. Adult height in Turkish patients with Turner syndrome without growth hormone treatment. Turk J Pediatr 2008;50:415-417.
39. Van den Broeck J, Massa GG, Attanasio A, Matranga A, Chaussain JL, Price DA, Aarskog D, Wit JM. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr 1995;127:729-735.
40. Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO; KIGS International Board. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 2007;61:105-110.
41. Davenport ML. Growth hormone therapy in Turner syndrome. Pediatr Endocrinol Rev. 2012;9(Suppl 2):723-724.
42. Özgen İT, Adal E, Ünüvar T, Önal H, Sarıkaya AS, Akın L. Response to growth hormone therapy in patients with Turner syndrome. Turk Arch Ped 2013;48:294-298.
43. Hughes IP, Choong CS, Harris M, Ambler GR, Cutfield WS, Hofman PL, Cowell CT, Werther G, Cotterill A, Davies PS; Australasian Paediatric Endocrine Group (APEG). Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response. Clin Endocrinol (Oxf) 2011;74:473-480.
44. Ranke MB, Schweizer R, Martin DD, Ehehalt S, Schwarze CP, Serra F, Binder G. Analyses from a centre of short- and long-term growth in Turner’s syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels. Horm Res Paediatr 2012;77:214-221.
45. Darendeliler F, Bas F, Berberoglu M, Öcal G, Günöz H, Darcan Ş, Bundak R, Arslanoğlu İ, Yüksel B, Bideci A. Turner Sendromunda büyüme hormonu tedavi sonuçlarının değerlendirilmesi: Türkiye KIGS verileri (Pfizer Uluslararası büyüme veritabanı) veritabanı analiz sonuçları. Çocuk Dergisi 2005;5:21-26. (in Turkish)
46. Darendeliler F, Aycan Z, Cetinkaya E, Vidilisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Arslanoglu I, Bundak R. Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome. Horm Res 2007;68:1-7. Epub 2007 Jan 5
47. Yeşilkaya E, Bereket A, Darendeliler F, Baş F, Poyrazoğlu Ş, Küçükemre Aydın B, Darcan Ş, Dündar B, Büyükinan M, Kara C, Sarı E, Adal E, Akıncı A, Atabek ME, Demirel F, Çelik N, Özkan B, Özhan B, Orbak Z, Ersoy B, Doğan M, Ataş A, Turan S, Gökşen D, Tarım Ö, Yüksel B, Ercan O, Hatun Ş, Şimşek E, Ökten A, Abacı A, Döneray H, Özbek MN, Keskin M, Önal H, Akyürek N, Bulan K, Tepe D, Emeksiz HC, Demir K, Kızılay D, Topaloğlu AK, Eren E, Özen S, Abalı S, Akın L, Selver Eklioğlu B, Kaba S, Anık A, Baş S, Ünüvar T, Sağlam H, Bolu S, Özgen T, Doğan D, Deniz Çakır E, Şen Y, Andıran N, Çizmecioğlu F, Evliyaoğlu O, Karagüzel G, Pirgon Ö, Çatlı G, Can HD, Gürbüz F, Binay Ç, Baş VN, Fidancı K, Polat A, Gül D, Açıkel C, Demirbilek H, Cinaz P, Bondy C. Turner syndrome and associated problems in Turkish children: a multicenter study. J Clin Res Pediatr Endocrinol 2015;7:27-36.
48. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 2008;93:352-357. Epub 2007 Nov 13.
49. Ranke MB, Lindberg A; KIGS International Board. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J Clin Endocrinol Metab 2010;95:1229-1237. Epub 2010 Jan 22
50. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M; European Society of Paediatric Endocrinology. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005;152:165-170.
51. Aydın BK, Aycan Z, Sıklar Z, Berberoğlu M, Ocal G, Cetinkaya S, Baş VN, Kendirci HN, Cetinkaya E, Darcan S, Gökşen D, Evliyaoğlu O, Sükür M, Baş F, Darendeliler F. Adherence to growth hormone therapy: results of a multicenter study. Endocr Pract 2014;20:46-51.
52. Kappelgaard AM, Laursen T. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age. Growth Horm IGF Res 2011;21:305-313. Epub 2011 Oct 20
53. Kapoor RR, Burke SA, Sparrow SE, Hughes IA, Dunger DB, Ong KK, Acerini CL. Monitoring of concordance in growth hormone therapy. Arch Dis Child 2008;93:147-148. Epub 2007 Sep 3
54. Smith SL, HindmarSh PC, Brook CG, Compliance with growth hormone treatment-are they getting it? Arch Dis Child 1993;68:91-93.
55. Cutfield WS, Derraik JG, Gunn AJ, Reid K, Delany T, Robinson E, Hofman PL. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One 2011;6:16223.